Germany Clinical Diagnostics Market Analysis

Germany Clinical Diagnostics Market Analysis


$ 3999

Germany's clinical diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022-30 and will reach $3.50 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Merck and others.

ID: IN10DEHS003 CATEGORY: Healthcare Services GEOGRAPHY: Germany AUTHOR: Nandini Shah

Buy Now

Germany Clinical Diagnostic Market Executive Summary

The Germany Clinical Diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $3.50 Bn in 2030. Clinical diagnostics is a discipline of medicine that involves the use of laboratory tests and other diagnostic tools to assess a patient's health and detect the presence of diseases or disorders. These tests, which can be performed on blood, urine, tissue samples, or other physiological fluids, can offer data on a variety of factors, including biochemical, genetic, and immunological indicators. Clinical diagnostics can be utilized for a number of objectives, including disease diagnosis, disease progression monitoring, disease risk screening, and therapeutic decision-making.

Immunochemistry, molecular diagnostics, clinical microbiology, hematology, and other sectors compose the German clinical diagnostics market. Immunochemistry is currently the market's largest category, accounting for the majority of sales. This is primarily because immunoassays are widely used in clinical laboratories for the diagnosis of infectious illnesses, malignancies, and autoimmune disorders in Germany.

germany clinical diagnostics market analysis

Market Dynamics

Market Growth Drivers

The prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer is on the rise in Germany, which is driving the demand for diagnostic tests. According to the Federal Statistical Office of Germany, the number of people diagnosed with diabetes in Germany increased from 6.9 Mn in 2009 to 7.6 Mn in 2019, representing a growth of 10%. Similarly, the number of cancer cases in Germany is projected to increase from 492,000 in 2020 to 583,000 in 2040, representing a growth of 18%. The aging population in Germany is also a major driver of growth in the clinical diagnostics market, as elderly people are more prone to chronic diseases and require more frequent diagnostic tests.

According to the Federal Statistical Office of Germany, the proportion of the population aged 65 years and over is projected to increase from 21% in 2020 to 28% in 2040. The development of new and advanced diagnostic technologies is also driving the growth of the clinical diagnostics market in Germany. For example, the use of next-generation sequencing (NGS) is increasing in molecular diagnostics, allowing for faster and more accurate genetic testing. According to a report by Grand View Research, the NGS market in Germany is projected to grow at a CAGR of 14.5% from 2020 to 2027. Point-of-care testing (POCT) devices are becoming increasingly popular in Germany, as they allow for rapid diagnosis and monitoring of diseases.

Market Restraints

Germany has a strict regulatory environment for clinical diagnostics products, which can create barriers to entry for new players and slow down the approval process for new products. This can lead to delays in the commercialization of innovative products and limit the growth of the market. According to a report by Transparency Market Research, the regulatory hurdles in Germany have made it difficult for small and medium-sized enterprises to enter the market. The high cost of diagnostic tests can be a barrier to access for patients, particularly those who are uninsured or underinsured. This can limit the demand for diagnostic tests and slow down the growth of the market.

According to a report by the Organisation for Economic Co-operation and Development (OECD), the cost of healthcare in Germany is among the highest in Europe, with spending on healthcare accounting for 11.1% of GDP in 2019. There is a shortage of skilled labor in the clinical diagnostics industry in Germany, particularly in the areas of molecular diagnostics and bioinformatics. This can limit the ability of companies to innovate and develop new products, and can also impact the quality of diagnostic tests. According to a report by the German Federal Employment Agency, there is a shortage of skilled labor in the healthcare industry, with an estimated 100,000 vacancies in the sector in 2020. The COVID-19 pandemic has had a significant impact on the clinical diagnostics market in Germany, with disruptions to supply chains, delays in testing, and reduced demand for non-COVID-19 diagnostic tests. While the pandemic has also created opportunities for the market, such as the demand for COVID-19 testing, it has also created significant challenges that could impact the growth of the market in the short term.

Competitive Landscape

Key Players

  • Abbott
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Siemens
  • Qiagen NV
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • Merk
  • BD
  • Nordwest Clinic

Healthcare Policies and Regulatory Landscape

Health Insurance Act (Sozialgesetzbuch - SGB) is the primary legislation governing healthcare in Germany, including the reimbursement of diagnostic tests by the statutory health insurance system. The SGB outlines the criteria for the reimbursement of medical services, including diagnostic tests, and establishes a system for negotiating reimbursement rates with healthcare providers and laboratories. German Medical Association (Bundesärztekammer - BÄK): The BÄK is the professional association representing physicians in Germany. The BÄK is responsible for setting professional standards for physicians, including standards for the use and interpretation of diagnostic tests.

Medical Devices Act (Medizinproduktegesetz - MPG) is the primary regulation governing medical devices in Germany, including diagnostic devices. The MPG outlines requirements for the safety, performance, and labeling of medical devices, as well as requirements for clinical evaluation and post-market surveillance. In 2017, the MPG was revised to align with the European Union's Medical Devices Regulation (MDR), which came into effect in 2021.

Reimbursement Scenario

The reimbursement scenario for clinical diagnostics in Germany is complex and can vary depending on the type of test, the indication, and the healthcare setting. Generally, diagnostic tests are reimbursed by the statutory health insurance system, which covers the majority of the population in Germany. The reimbursement system in Germany is based on a diagnosis-related group (DRG) system, which groups patients into categories based on their diagnosis and treatment. Diagnostic tests are typically reimbursed as part of the overall DRG payment for the patient's hospitalization or outpatient visit. In addition to the DRG system, there are also specific reimbursement codes for diagnostic tests, known as laboratory fee schedules. These codes are used to bill for laboratory tests performed in independent laboratories and can vary depending on the type of test and the region of the country. The reimbursement rates for diagnostic tests in Germany are negotiated between the statutory health insurance funds and the associations representing healthcare providers and laboratories. These negotiations can be complex and can consider factors such as the cost of the test, the clinical benefit, and the competitive landscape.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Clinical Diagnostics Market Segmentation

By Test

  • Lab Test
  • Imaging Test
  • Other Tests

By Product

  • Instruments
  • Reagents
  • Other Products

By End User (Revenue, USD Bn)

  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-care Testing
  • Other End Users

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 12 March 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up